SNY - Sanofi chief scientific officer leaving company: report
2024-05-08 16:45:51 ET
More on Sanofi
- Sanofi Q1: Wait And See For Now (Downgrade)
- Sanofi: Q1 Earnings Reflect Growth And Strategic Acquisitions (Rating Upgrade)
- Sanofi 2024 Q1 - Results - Earnings Call Presentation
- Bristol, Sanofi, Takeda gain positive CHMP recommendations
- Sanofi Non-GAAP EPS of €1.78, revenue of €10.46B; reaffirms FY24 business EPS guidance